{"id":78247,"date":"2026-08-24T20:44:09","date_gmt":"2026-08-24T20:44:09","guid":{"rendered":"https:\/\/www.europesays.com\/germany\/78247\/"},"modified":"2026-08-24T20:44:09","modified_gmt":"2026-08-24T20:44:09","slug":"market-one-mustgrow-biologics-receives-first-bayer-milestone-payment","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/germany\/78247\/","title":{"rendered":"Market One: MustGrow Biologics Receives First Bayer Milestone Payment"},"content":{"rendered":"

<\/p>\n

Vancouver, British Columbia–(Newsfile Corp. – August 24, 2026) – Market One (“Market One”), a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors.<\/p>\n

Market One delivers content creation and distribution through a suite of products across video, editorial, and social media.<\/p>\n

MustGrow Biologics Corp.: Advancing biocontrol technology commercialization<\/p>\n

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) reviewed its receipt of the first Bayer milestone payment, including recognition of its mustard-based biocontrol technology, TerraMG\u2122, exclusive rights for European, Middle Eastern, and African soil applications, and potential combined payments of US$35-$40 million over several years.<\/p>\n

The article examines MustGrow’s strategic commercialization efforts with Bayer, against the backdrop of growing global demand for sustainable agricultural solutions and expanding investment opportunities in regenerative farming and biocontrol technologies.<\/p>\n

\n

Cannot view this video? Visit:
https:\/\/www.youtube.com\/watch?v=y4-M3F-vRLM<\/a>\u00a0<\/p>\n

To read the full article, please visit BNN Bloomberg at:\u00a0
https:\/\/www.bnnbloomberg.ca\/investment-trends\/2026\/08\/24\/first-bayer-milestone-payment-received-for-mustard-based-biocontrol\/<\/a><\/p>\n

About MustGrow Biologics Corp.<\/p>\n

MustGrow Biologics is a Saskatchewan-based agriculture biotechnology company commercializing mustard seed-derived biological solutions – including TerraMG\u2122 soil biocontrol and TerraSante\u2122 biofertility – backed by approximately 110 issued and pending patents. The company pursues a capital-efficient licensing model, partnering with global crop science leaders such as Bayer, which holds exclusive rights across Europe, the Middle East and Africa under an agreement valued at approximately USD $35-40 million before royalties and manufacturing sales.<\/p>\n

Learn more at mustgrow.ca<\/a>.<\/p>\n

Follow MustGrow Biologics on LinkedIn<\/a>, Facebook<\/a>, X<\/a>, and YouTube<\/a>.<\/p>\n

To view the source version of this press release, please visit https:\/\/www.newsfilecorp.com\/release\/311150<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Vancouver, British Columbia–(Newsfile Corp. – August 24, 2026) – Market One (“Market One”), a marketing agency for public…\n","protected":false},"author":2,"featured_media":78248,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21161],"tags":[21182,94,1447,95,666,8207,3629,8208,8209,57347,1380,45460,8210,8211,3678],"class_list":["post-78247","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bayer","tag-bayer","tag-business","tag-business-news","tag-economy","tag-finance","tag-financial-information","tag-investing","tag-investor","tag-market-news","tag-newsfile","tag-press-releases","tag-sedar","tag-stock-research","tag-stock-valuation","tag-the-globe-and-mail"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/78247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/comments?post=78247"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/78247\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media\/78248"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media?parent=78247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/categories?post=78247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/tags?post=78247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}